BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

318 related articles for article (PubMed ID: 9154767)

  • 1. Thalidomide for the treatment of oral aphthous ulcers in patients with human immunodeficiency virus infection. National Institute of Allergy and Infectious Diseases AIDS Clinical Trials Group.
    Jacobson JM; Greenspan JS; Spritzler J; Ketter N; Fahey JL; Jackson JB; Fox L; Chernoff M; Wu AW; MacPhail LA; Vasquez GJ; Wohl DA
    N Engl J Med; 1997 May; 336(21):1487-93. PubMed ID: 9154767
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Thalidomide for the treatment of esophageal aphthous ulcers in patients with human immunodeficiency virus infection. National Institute of Allergy and Infectious Disease AIDS Clinical Trials Group.
    Jacobson JM; Spritzler J; Fox L; Fahey JL; Jackson JB; Chernoff M; Wohl DA; Wu AW; Hooton TM; Sha BE; Shikuma CM; MacPhail LA; Simpson DM; Trapnell CB; Basgoz N
    J Infect Dis; 1999 Jul; 180(1):61-7. PubMed ID: 10353862
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Thalidomide in low intermittent doses does not prevent recurrence of human immunodeficiency virus-associated aphthous ulcers.
    Jacobson JM; Greenspan JS; Spritzler J; Fox L; Fahey JL; Jackson JB; Chernoff M; Wohl DA; Pulvirenti JJ; Hooton TM; Shikuma C
    J Infect Dis; 2001 Jan; 183(2):343-346. PubMed ID: 11120935
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Thalidomide Celgene Corp.
    Bruyn GA
    IDrugs; 1998 Aug; 1(4):490-500. PubMed ID: 18465584
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Thalidomide as therapy for human immunodeficiency virus-related oral ulcers: a double-blind placebo-controlled clinical trial.
    Ramirez-Amador VA; Esquivel-Pedraza L; Ponce-de-Leon S; Reyes-Teran G; Gonzalez-Guevara M; Ponce-de-Leon S; Sierra-Madero JG
    Clin Infect Dis; 1999 Apr; 28(4):892-4. PubMed ID: 10825055
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Thalidomide effective for oral ulcers.
    Posit Aware; 1996; 7(1):5. PubMed ID: 11363120
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Crossover study of thalidomide vs placebo in severe recurrent aphthous stomatitis.
    Revuz J; Guillaume JC; Janier M; Hans P; Marchand C; Souteyrand P; Bonnetblanc JM; Claudy A; Dallac S; Klene C
    Arch Dermatol; 1990 Jul; 126(7):923-7. PubMed ID: 2193629
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Silver nitrate cautery in aphthous stomatitis: a randomized controlled trial.
    Alidaee MR; Taheri A; Mansoori P; Ghodsi SZ
    Br J Dermatol; 2005 Sep; 153(3):521-5. PubMed ID: 16120136
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Thalidomide and HIV: several possible uses.
    Smith D
    AIDS Treat News; 1995 Apr; (no 221):1-4. PubMed ID: 11362402
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Zidovudine in asymptomatic human immunodeficiency virus infection. A controlled trial in persons with fewer than 500 CD4-positive cells per cubic millimeter. The AIDS Clinical Trials Group of the National Institute of Allergy and Infectious Diseases.
    Volberding PA; Lagakos SW; Koch MA; Pettinelli C; Myers MW; Booth DK; Balfour HH; Reichman RC; Bartlett JA; Hirsch MS
    N Engl J Med; 1990 Apr; 322(14):941-9. PubMed ID: 1969115
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Growing interest in thalidomide.
    Lowell B
    GMHC Treat Issues; 1995 May; 9(5):4-6. PubMed ID: 11362414
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment for weight loss, tuberculosis and AIDS?
    Treat Rev; 1995 Nov; (no 20):4. PubMed ID: 11363021
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Safety, tolerability, and pharmacokinetic effects of thalidomide in patients infected with human immunodeficiency virus: AIDS Clinical Trials Group 267.
    Wohl DA; Aweeka FT; Schmitz J; Pomerantz R; Cherng DW; Spritzler J; Fox L; Simpson D; Bell D; Holohan MK; Thomas S; Robinson W; Kaplan G; Teppler H;
    J Infect Dis; 2002 May; 185(9):1359-63. PubMed ID: 12001058
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A randomized, double-blind, placebo-controlled trial of pentoxifylline for the treatment of recurrent aphthous stomatitis.
    Thornhill MH; Baccaglini L; Theaker E; Pemberton MN
    Arch Dermatol; 2007 Apr; 143(4):463-70. PubMed ID: 17438178
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Thalidomide for treatment of oral aphthous ulcers in patients with human immunodeficiency virus: case report and review.
    Ball SC; Sepkowitz KA; Jacobs JL
    Am J Gastroenterol; 1997 Jan; 92(1):169-70. PubMed ID: 8995965
    [No Abstract]   [Full Text] [Related]  

  • 16. Inflammatory pseudotumor causing small bowel obstruction and mimicking lymphoma in a patient with AIDS: clinical improvement after initiation of thalidomide treatment.
    Aboulafia DM
    Clin Infect Dis; 2000 May; 30(5):826-31. PubMed ID: 10816156
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Thalidomide for mouth ulcers and wasting.
    Baker R
    BETA; 1995 Dec; ():8. PubMed ID: 11363016
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Current role of thalidomide in HIV-positive patients with recurrent aphthous ulcerations.
    Shetty K
    Gen Dent; 2007; 55(6):537-42. PubMed ID: 18050580
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Thalidomide study.
    Proj Inf Perspect; 1997 Jul; (22):14-5. PubMed ID: 11364572
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Thalidomide as treatment of refractory aphthous ulceration related to human immunodeficiency virus infection.
    Paterson DL; Georghiou PR; Allworth AM; Kemp RJ
    Clin Infect Dis; 1995 Feb; 20(2):250-4. PubMed ID: 7742424
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.